Literature DB >> 16707577

Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.

Patrizia Farci1, Isabella Quinti, Stefania Farci, Harvey J Alter, Rita Strazzera, Elvia Palomba, Alessandra Coiana, Daniele Cao, Anna Maria Casadei, Ritarella Ledda, Raffaele Iorio, Angela Vegnente, Giacomo Diaz, Pier-Angelo Tovo.   

Abstract

Perinatal infection with hepatitis C virus (HCV) is characterized by a wide range of alanine aminotransferase (ALT) levels. The mechanisms responsible for this variability are unknown. We examined whether the evolution of the HCV quasispecies was associated with different ALT profiles in perinatally infected children. Sequences within HCV envelope 1 and 2 genes, inclusive of the hypervariable region 1, the viral load, and the nascent humoral immunity were analyzed in serial serum samples from 12 perinatally infected children prospectively followed for a median of 53 months. These patients were selected to represent two different ALT patterns during the first year of life: 6 had high levels (maximum values ranging from 4.2 to 30 times the normal upper limit), and 6 had normal or slightly elevated levels (< 2 times the normal upper limit). Two patterns of viral evolution were identified according to the ALT profiles. Biochemical evidence of hepatic injury was invariably associated with a mono- or oligoclonal viral population, whereas mild or no liver damage correlated with the early emergence of a heterogeneous viral quasispecies. Consistent with selective immune pressure, amino acid changes occurred almost exclusively within the hypervariable region 1 and were temporally associated with antibody seroconversion; at this time, the difference in genetic diversity between the two groups was highly significant (P = 0.002). The two patterns of viral evolution persisted over time and did not correlate with viral load or genotype. Our study demonstrates that, in perinatally infected children, the evolution of HCV quasispecies correlates with hepatic injury. The sequences reported in this paper have been deposited in the GenBank database (accession nos. DQ 504441-DQ 507112).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707577      PMCID: PMC1482517          DOI: 10.1073/pnas.0602546103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Neonatal adaptive immunity comes of age.

Authors:  Becky Adkins; Claude Leclerc; Stuart Marshall-Clarke
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

2.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.

Authors:  M Nei; T Gojobori
Journal:  Mol Biol Evol       Date:  1986-09       Impact factor: 16.240

3.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.

Authors:  Robert Thimme; Jens Bukh; Hans Christian Spangenberg; Stefan Wieland; Janell Pemberton; Carola Steiger; Sugantha Govindarajan; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

6.  Lack of protective immunity against reinfection with hepatitis C virus.

Authors:  P Farci; H J Alter; S Govindarajan; D C Wong; R Engle; R R Lesniewski; I K Mushahwar; S M Desai; R H Miller; N Ogata
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

7.  Perinatal transmission and viral evolution of hepatitis C virus quasispecies in infants coinfected with HIV.

Authors:  Henry Pollack; Zhiying Hou; Austin L Hughes; William Borkowsky
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-01       Impact factor: 3.731

8.  Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion.

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Juan F Gallegos-Orozco; Marek Radkowski; Debra M Adair; Marek Nowicki; Eva Operskalski; Zelma Buskell; Leonard B Seeff; Hugo Vargas; Jorge Rakela
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

9.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Vertical transmission of the hepatitis C virus to infants of anti-human immunodeficiency virus-negative mothers: molecular evolution of hypervariable region 1 in prenatal and perinatal or postnatal infections.

Authors:  C Caudai; M Battiata; M P Riccardi; M Toti; P Bonazza; M G Padula; M Pianese; P E Valensin
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  27 in total

1.  Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively.

Authors:  Jean-Christophe Meunier; Jens Bukh; Giacomo Diaz; Pier-Angelo Tovo; Anna Maria Casadei; Isabella Quinti; Raffaele Iorio; Suzanne Emerson; Robert H Purcell; Patrizia Farci
Journal:  J Infect Dis       Date:  2011-10-17       Impact factor: 5.226

2.  Monitoring of hepatitis C virus quasispecies in chronic infection by matrix-assisted laser desorption ionization-time of flight mass spectrometry mutation detection.

Authors:  Carmen Yea; Jens Bukh; Melissa Ayers; Eve Roberts; Mel Krajden; Raymond Tellier
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission.

Authors:  Ariane Larouche; Geneviève Gaëtan; Nabil El-Bilali; Mathieu Quesnel-Vallières; Steven R Martin; Fernando Alvarez; Naglaa H Shoukry; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

Review 4.  Vertical transmission of hepatitis C virus: Current knowledge and perspectives.

Authors:  Chun-Yan Yeung; Hung-Chang Lee; Wai-Tao Chan; Chun-Bin Jiang; Szu-Wen Chang; Chih-Kuang Chuang
Journal:  World J Hepatol       Date:  2014-09-27

5.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

Review 6.  To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy.

Authors:  Mohamed A Mekky
Journal:  World J Hepatol       Date:  2014-04-27

Review 7.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

8.  Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.

Authors:  Joshua D Ramsay; Ryan Evanoff; Robert H Mealey
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

9.  Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

Authors:  Hurng-Yi Wang; Ming-Hung Chien; Hsiang-Po Huang; Hsiao-Chi Chang; Chung-Che Wu; Pei-Jer Chen; Mei-Hwei Chang; Ding-Shinn Chen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

10.  Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy.

Authors:  Ahmed A Al-Qahtani; George Kessie; Damian Dela Cruz; Faleh Z Al-Faleh; Mohammed N Al-Ahdal
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.